Total Number of Communication Reports: 54
Monthly communication reports in the last 6 months: 0
End date of the last completed financial year: 2018-12-31
Government Institution | Funding Received in Last Financial Year | Funding Expected in Current Financial Year |
---|---|---|
Australian Government (DFAT) | $2,822,678.00 | Yes |
German Government (BMBF) | $467,101.00 | Yes |
Irish Aid | $1,164,839.00 | Yes |
National Institutes of Health (NIH) | $30,900.00 | Yes |
Netherlands Government (OTA) | $3,760,587.00 | Yes |
Swiss Government (DEZA/SDC) | $1,616,834.00 | Yes |
UK Government (Department of Health) | $5,031,648.00 | Yes |
UK Government (DFID) | $14,986,801.00 | Yes |
US Government (USAID) | $1,054,178.00 | Yes |
Address:
Route de Pré-Bois 20, ICC
Cointrin, Geneva 1216
Switzerland
Telephone number:
+41-22-555-0336
Web address:
www.mmv.org
Matthew Doherty, Manager, Donor and Stakeholder Relations
MMV Medicines for Malaria Venture is not a subsidiary of any other parent companies.
MMV Medicines for Malaria Venture is not a coalition.
The activities of MMV Medicines for Malaria Venture are not controlled or directed by another individual, organization or corporation with a direct interest in the outcome of this undertaking.
MMV Medicines for Malaria Venture does not have any subsidiaries that could have a direct interest in the outcome of the undertaking
Paul Moen | Public offices held
Firm: Earnscliffe Strategy Group Inc.